Predicting the future impact of lung cancer for men and women
Predicting the future impact of lung cancer for men and women
Cancer Council NSW2009–2015
Researchers based at Cancer Council NSW have found that lung cancer rates for women are still rising, highlighting the need to further strengthen measures to stop smoking. By calculating lung cancer trends and projections, they have provided vital data that will help inform planning for the health care needs of patients in the future.
Background
Lung cancer is one of the most common cancers diagnosed in Australia and the leading cause of cancer death. Australia has little current data on how many people are going to need treatment for lung cancer in the future. Calculating the five-year prevalence rate of lung cancer highlights the number of people who are undergoing initial treatment, receiving ongoing post-treatment follow-up care, or who are receiving end-of-life care. This information will help Australia to plan future health services for the likely number of people who will require these intensive levels of care.
The research
The team analysed lung cancer cases diagnosed from 1983 – 2007 in NSW and found that for men, overall rates of lung cancer have declined over the past two decades. For women, unfortunately, there has been a rise in overall rates.
Generally speaking, there is a 20–30 year lag between smoking and the onset of lung cancer. In Australia, smoking rates among men started to drop in the 1950s, which resulted in a decrease in lung cancer rates from the 1980s onwards.
The reduction in smoking rates among women occurred much later and, therefore, it will be several years before the increase in lung cancer rates in women hits a peak and begins to decline. In fact, estimates based on the data predict that lung cancer prevalence for women in NSW will overtake that of men by 2017.
The impact
This research has highlighted the need for further strengthening of current smoking cessation measures in young people and women.
This should be considered a high priority in Australia since most lung cancers are attributable to smoking. These measures will help inform strategies to reduce the incidence of, and prevent further deaths from, lung cancer in the future. Improving early diagnosis is also vital, as the majority of lung cancer patients are diagnosed with advanced disease – which explains why survival rates are currently so low.
This research has provided a vital understanding of lung cancer trends, which will help inform future assessment of the resources and infrastructure needed to meet the demand for health services
Research team
Dr Xu Qin Yu Cancer Council NSW
Ms Clare Kahn Ms Qingwei Luo Associate Professor Freddy Sitas Professor Dianne O’Connell